CBD may be a safer and effective adjunctive therapy for schizophrenia, with antipsychotic, anxiolytic, and neuroprotective effects. Research is needed to fully understand its potential benefits and interactions with traditional antipsychotics.
Review on neuroprotective properties of and its compounds, including antioxidant, anti-inflammatory, and neuroregenerative effects. Benefits in Alzheimer's and Parkinson's models due to polyphenols like anthocyanins. Potential as functional food ingredient discussed. Valuable insights for brain health strategies.
Study investigated cinnamomum cassia for antioxidant potential in lupus redox pathways. Potential novel therapy for lupus due to antioxidant properties, may impact disease activity.
Seed oils from Maxim and Hayata seeds have strong antioxidant and neuroprotective effects, reducing ROS levels and preventing amyloid β and tau protein aggregation in neuron cells. This research could lead to potential therapies for neurodegenerative diseases like Alzheimer's.
L. brownii extracts improve motor dysfunction, increase neuron count, reduce oxidative stress, and modulate p62-Keap1-Nrf2 pathway in PD mice. Ethanol extract more effective due to higher phenolic acid glyceride content.
Researchers analyzed Griseb. plant leaves for phenolic content and tested anti-inflammatory properties on animals with neuroinflammation. Results show compounds cross the BBB, reduce inflammation markers, and improve activity levels. This could lead to new treatments for inflammation-related conditions.
The study found that saponin from Polygala Willd can help with dementia. It provides new evidence for using these components in dementia treatment.